EA3738 CTO, Faculté Médecine Lyon Sud
Pharmaceuticals - Oullins, Auvergne-Rhône-Alpes, France
EA3738 CTO, Faculté Médecine Lyon Sud Employees
EA3738 CTO, Faculté Médecine Lyon Sud Details
Drapeau français Drapeau anglais * Welcome * About Us * Activities * Skills * Team o Concept o Members o Partners - Collaborations * Technical Capacity * Publications * Liens o Clinical o Modelling o Learned Societies * Contacts Structure of the team Within the structure "Cancer - Gerland Lyon Sud", the Phase I trials in Oncology Platform was created in 2003. Modern and original instrument, the platform wants to be at the service of patients, industry and medical progress. At the European level, the "Claude Bernard University and Civil Hospitals of Lyon HCL/UCBL platform of phase I trials" is the first of its kind, bringing together on the same site all the skills and technologies necessary for earlier preclinical and clinical development of antineoplastic agents. As a result of a close working partnership between Hospices Civils de Lyon and Claude Bernard University, the pharmaceutical industry now has easy access to multiple skills in the areas of clinical oncology, pharmacology and mathematical modelling of therapeutic effects. The platform is run by a team of experienced clinicians and researchers in a high level technological environment. Our principal motivation is the development of original methodology and therapeutic innovation giving hope to patients suffering from cancer.
EA3738 CTO, Faculté Médecine Lyon Sud Technologies
Load Balancers
Apache